00589nas a2200217   4500000000100000000000100001008004100002100001500043700001300058700001600071700001900087700001400106700001700120700001500137700001900152700001300171245015500184300001200339490000600351022001400357       2018                            d1 aJ. Voorham1 aN. Roche1 aH. Benhaddi1 aM. van der Tol1 aV. Carter1 aJ. van Boven1 aL. Bjermer1 aM. Miravitlles1 aD. Price00aReal-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK  ae0220510 v8  a2044-6055